ReGenesys EU SA

ReGenesys EU reported total assets of 7,609 € at the end of the 2021 financial year (annual accounts filed with the NBB on 26 Sep 2023).

Company number (CBE) 0544.577.301 · VAT BE0544577301
3001 Leuven
active in Manufacture of basic pharmaceutical products (NACE 21100)
operating since 30 Dec 2013 (≈ 13 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of ReGenesys EU shows with a free account.

See the score
Profile
SA since 2013
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2021

Net result−10,187 €
Equity−20,027 €
Cash7,609 €
EBITDA−9,831 €
Total assets7,609 €
Solvency-263.2%
The line marks its sector median: 56.0% (144 companies).

Change 2018 → 2021: Total assets -14 %

Accounts of the company itself (not consolidated).

The full file covers 6 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

ReGenesys EU's annual accounts

20212020201920182017
Net result−10,187 €
Equity−20,027 €
Cash7,609 €
EBITDA−9,831 €
Total assets7,609 €

Filed annual accounts

  • Year ended 31 Dec 2021filed on 26 Sep 2023
  • Year ended 31 Dec 2020filed on 11 Aug 2021
  • Year ended 31 Dec 2019filed on 30 Jul 2020
  • Year ended 31 Dec 2018filed on 30 Jul 2019
  • Year ended 31 Dec 2017filed on 20 Aug 2018

ReGenesys EU's financial analysis

Management and control of ReGenesys EU

1 active director(s) in the register.

ReGenesys EU's shareholders and holdings →

ReGenesys EU's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0544.577.301
VAT number
BE0544577301
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SA
Incorporated
30 Dec 2013
Registered office
3001 Leuven
Latest accounts
2021 · filed on 26 Sep 2023
Activity
Manufacture of basic pharmaceutical products (NACE 21100)

ReGenesys EU (SA) has been based in Leuven since 2013, active in: manufacture of basic pharmaceutical products. For 2021, it reports a net loss of 10,187 € and equity of −20,027 €; its revenue is not published. Its solvency stands at -263.2%, below the median of its sector (56.0%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to ReGenesys EU

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about ReGenesys EU

What is the revenue of ReGenesys EU?

ReGenesys EU files its accounts in a format where revenue is optional: it is not published for 2021.

What is the VAT number of ReGenesys EU?

In Belgium, the VAT number is the company number prefixed with BE: BE0544577301 for ReGenesys EU, if the company is VAT-registered. Its company number (CBE) is 0544.577.301.

Where is the registered office of ReGenesys EU?

According to the CBE register, the registered office of ReGenesys EU is in 3001 Leuven.

What is the equity of ReGenesys EU?

At the close of the 2021 financial year, the equity of ReGenesys EU amounts to -20,027 €, a solvency of -263.2% of total assets.

Who manages ReGenesys EU?

The register lists 1 active mandates at ReGenesys EU. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of ReGenesys EU

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 11 Jul 2026

No credit card, no commitment.

What each plan unlocks →